Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuang Shang

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Acta Pharmaceutica Sinica. B|November 11, 2024
PKC<i>α</i> inhibitors promote breast cancer immune evasion by maintaining PD-L1 stabilityJiaojiao Yu, Yujin Xiang, Yuzhen Gao, et al.
Science Translational Medicine|January 5, 2022
TRIB3 reduces CD8<sup>+</sup> T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancerShuang Shang, Yu-Wei Yang, Fei Chen, et al.
Cancer Letters|January 14, 2020
Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signalingJiao-Jiao Yu, Dan-Dan Zhou, Bing Cui, et al.
Nature Communications|July 23, 2020
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic targetJiao-Jiao Yu, Dan-Dan Zhou, Xiao-Xiao Yang, et al.
Immunity|August 18, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Gastroenterology|October 27, 2018
TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and TumorigenesisFang Hua, Shuang Shang, Yu-Wei Yang, et al.
Nature Communications|December 10, 2020
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradationKe Li, Feng Wang, Zhao-Na Yang, et al.
Cancer Cell|May 10, 2017
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated SenescenceKe Li, Feng Wang, Wen-Bin Cao, et al.
Science Translational Medicine|March 25, 2021
Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stabilityKe Li, Ting-Ting Zhang, Chen-Xi Zhao, et al.
Nature Communications|December 18, 2019
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcriptionJin-Mei Yu, Wei Sun, Zhen-He Wang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Acta Pharmaceutica Sinica. B|November 11, 2024
PKC<i>α</i> inhibitors promote breast cancer immune evasion by maintaining PD-L1 stabilityJiaojiao Yu, Yujin Xiang, Yuzhen Gao, et al.
Science Translational Medicine|January 5, 2022
TRIB3 reduces CD8<sup>+</sup> T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancerShuang Shang, Yu-Wei Yang, Fei Chen, et al.
Cancer Letters|January 14, 2020
Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signalingJiao-Jiao Yu, Dan-Dan Zhou, Bing Cui, et al.
Nature Communications|July 23, 2020
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic targetJiao-Jiao Yu, Dan-Dan Zhou, Xiao-Xiao Yang, et al.
Immunity|August 18, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Gastroenterology|October 27, 2018
TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and TumorigenesisFang Hua, Shuang Shang, Yu-Wei Yang, et al.
Nature Communications|December 10, 2020
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradationKe Li, Feng Wang, Zhao-Na Yang, et al.
Cancer Cell|May 10, 2017
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated SenescenceKe Li, Feng Wang, Wen-Bin Cao, et al.
Science Translational Medicine|March 25, 2021
Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stabilityKe Li, Ting-Ting Zhang, Chen-Xi Zhao, et al.
Nature Communications|December 18, 2019
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcriptionJin-Mei Yu, Wei Sun, Zhen-He Wang, et al.
Pageof 4